EDAP TMS S.A.'s EBIT is $-35M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
EDAP TMS S.A. (EDAP) currently reports a EBIT of $-35M as of June 2026. That compares with $-19M in the prior-year period — down 81.2% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore EDAP TMS S.A.'s EBIT history and peer comparisons.
EDAP TMS S.A.'s EBIT decreased from $-19M to $-35M — a 81.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
EDAP TMS S.A.'s EBIT of $-35M is lower than the Healthcare sector average of $23B. That is roughly 100.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
EDAP TMS S.A. reported $-35M in EBIT as of June 2026. That compares with $-19M in the prior-year period — down 81.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-35M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for EDAP TMS S.A., and consider following EDAP for alerts when major investors trade the stock.